Alliance Pharma PLC received a notification of major holdings from Slater Investments, a shareholder, on 5th October 2023. The reason for notification was an acquisition or disposal of voting rights. The total positions of Slater Investments show a 11.04% of voting rights attached to shares, with 0% through financial instruments, resulting in a total of 11.04% and a total number of voting rights held in the issuer of 59,620,631.
The details of the resulting situation on the date on which the threshold was crossed or reached indicate that 1.28% of direct voting rights and 9.76% of indirect voting rights are attached to shares. The notification also includes information about the full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, starting with the ultimate controlling natural person or legal entities, in this case, Mark Slater of Slater Investments.
The completion date of the notification was 5th October 2023, and the place of completion was supplied by Euroland.com.